In vitro display technologies are a group of methods used to display diverse antibody libraries on the surface of solid supports or particles like phage, yeast, ribosomes, and bacteria. They are powerful tools for the discovery and engineering of novel antibodies with desired binding properties and were first explored for antibody selection over 30 years ago.

Learn about high-throughput antibody expression & production techniques for faster therapeutic research, industrial-scale manufacturing, and improved panel diversity.

Explore advanced analytical techniques for antibody characterization, including mass spectrometry, high-throughput sequencing & bioinformatics for precision therapeutics.

Biointron's SVP of R&D, Lei Shi, PhD, discussed the processes of accelerating early discovery through HTP and high-speed antibody production during the Antibody Engineering & Therapeutics US 2023 conference in San Diego. Below is a summary of the talk.

Discover the methods like ELISA, SPR, and AI-driven high-throughput screening used to identify therapeutic antibodies, ensuring specificity, safety, and efficacy.